CXCR4 and glioma: Since Nordy can inhibit angiogenesis by regulating CXCR4-mediated production of VEGF by glioma cells [32], we attempted to confirm whether the combination of Nordy and the VEGF receptor tyrosine kinase inhibitor could enhance suppression of angiogenesis that was induced by GSCs (Figure 3F).